| Howard Ken Adolph, MD | |
|
2304 Hancock Dr Ste 4, Austin, TX 78756-2540 | |
| (512) 407-8444 | |
| (512) 407-8097 |
| Full Name | Howard Ken Adolph |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 25 Years |
| Location | 2304 Hancock Dr Ste 4, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215901368 | NPI | - | NPPES |
| K-9205 | Other | TX | STATE LICENSE |
| 87168N | Other | MEDICARE | |
| 87168N | Other | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | K-9205 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St David's Medical Center | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Anesthesiology Group Pllc | 0547256497 | 374 |
News Archive
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).
The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.
› Verified 5 days ago
| Entity Name | Austin Anesthesiology Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598724304 PECOS PAC ID: 0547256497 Enrollment ID: O20040424000086 |
News Archive
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).
The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.
› Verified 5 days ago
| Entity Name | Cardiovascular Anesthesiology,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316029325 PECOS PAC ID: 3173580867 Enrollment ID: O20041214000886 |
News Archive
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).
The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Howard Ken Adolph, MD Po Box 300087, Austin, TX 78703-0002 Ph: (512) 407-8444 | Howard Ken Adolph, MD 2304 Hancock Dr Ste 4, Austin, TX 78756-2540 Ph: (512) 407-8444 |
News Archive
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Improving staff training in care homes and reducing reliance on harmful medications saves thousands of pounds per year, as well as improving quality of life and reducing agitation in dementia, new research has demonstrated.
Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).
The next treatment for cancer might come from fish says a new research report published in the March 2010 print edition of the FASEB Journal (http://www.fasebj.org). In the report, scientists show that the omega-3 fatty acid, "docosahexaenoic acid" or "DHA," and its derivatives in the body kill neuroblastoma cancer cells.
› Verified 5 days ago
Dr. John W Wages, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4100 Duval Rd, Bldg Iii Suite 200, Austin, TX 78759 Phone: 512-485-7200 Fax: 512-485-7224 | |
Allison Rae Losey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2554 | |
Dr. James Patrick Fogarty Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8140 N Mopac Expy Ste 3-210, Austin, TX 78759 Phone: 512-343-2292 | |
Vijay K. Ravula, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Gary L. Mihm, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 919 E 32nd St, Austin, TX 78705 Phone: 512-476-7111 | |
Todd Paricio, M.D Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3801 N Lamar Blvd, Austin, TX 78756 Phone: 512-407-8444 Fax: 512-407-8097 | |
Dr. Rebecca R Porras, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy, Suite 570, Austin, TX 78705 Phone: 512-454-2454 Fax: 512-454-1532 |